Albemarle (ALB) Competitors

Albemarle presently has a consensus target price of $199.58, indicating a potential upside of 47.55%. AdvanSix has a consensus target price of $22.50, indicating a potential upside of 11.05%. Given Albemarle's stronger consensus rating and higher possible upside, research analysts clearly believe Albemarle is more favorable than AdvanSix.

92.9% of Albemarle shares are owned by institutional investors. Comparatively, 86.4% of AdvanSix shares are owned by institutional investors. 0.4% of Albemarle shares are owned by insiders. Comparatively, 5.0% of AdvanSix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Albemarle had 14 more articles in the media than AdvanSix. MarketBeat recorded 14 mentions for Albemarle and 0 mentions for AdvanSix. Albemarle's average media sentiment score of 0.74 beat AdvanSix's score of 0.00 indicating that Albemarle is being referred to more favorably in the media.

AdvanSix has lower revenue, but higher earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.2%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 3.2%. Albemarle pays out -47.5% of its earnings in the form of a dividend. AdvanSix pays out 173.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Albemarle has raised its dividend for 30 consecutive years and AdvanSix has raised its dividend for 2 consecutive years.

Albemarle has a beta of 1.34, suggesting that its stock price is 34% more volatile than the broader market. Comparatively, AdvanSix has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market.

AdvanSix has a net margin of 0.67% compared to Albemarle's net margin of -5.00%. Albemarle's return on equity of 5.22% beat AdvanSix's return on equity.

92.9% of Albemarle shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 0.4% of Albemarle shares are owned by company insiders. Comparatively, 3.1% of Cabot shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Cabot has lower revenue, but higher earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Albemarle has a beta of 1.34, meaning that its share price is 34% more volatile than the broader market. Comparatively, Cabot has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market.

Cabot has a net margin of 7.97% compared to Albemarle's net margin of -5.00%. Cabot's return on equity of 21.33% beat Albemarle's return on equity.

In the previous week, Albemarle had 12 more articles in the media than Cabot. MarketBeat recorded 14 mentions for Albemarle and 2 mentions for Cabot. Cabot's average media sentiment score of 0.87 beat Albemarle's score of 0.74 indicating that Cabot is being referred to more favorably in the news media.

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.2%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.2%. Albemarle pays out -47.5% of its earnings in the form of a dividend. Cabot pays out 35.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has raised its dividend for 30 consecutive years and Cabot has raised its dividend for 14 consecutive years.

Albemarle currently has a consensus price target of $199.58, suggesting a potential upside of 47.55%. Cabot has a consensus price target of $85.80, suggesting a potential downside of 0.57%. Given Albemarle's stronger consensus rating and higher possible upside, equities research analysts clearly believe Albemarle is more favorable than Cabot.

Chemours has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Albemarle has a beta of 1.34, indicating that its stock price is 34% more volatile than the broader market.

Albemarle has a net margin of -5.00% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Albemarle's return on equity.

In the previous week, Albemarle had 10 more articles in the media than Chemours. MarketBeat recorded 14 mentions for Albemarle and 4 mentions for Chemours. Albemarle's average media sentiment score of 0.74 beat Chemours' score of -0.08 indicating that Albemarle is being referred to more favorably in the news media.

76.3% of Chemours shares are owned by institutional investors. Comparatively, 92.9% of Albemarle shares are owned by institutional investors. 0.9% of Chemours shares are owned by insiders. Comparatively, 0.4% of Albemarle shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.8%. Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.2%. Chemours pays out -13.3% of its earnings in the form of a dividend. Albemarle pays out -47.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has increased its dividend for 30 consecutive years.

Chemours presently has a consensus target price of $24.10, suggesting a potential upside of 26.98%. Albemarle has a consensus target price of $199.58, suggesting a potential upside of 47.55%. Given Albemarle's stronger consensus rating and higher possible upside, analysts plainly believe Albemarle is more favorable than Chemours.

Chemours has higher revenue and earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

92.9% of Albemarle shares are owned by institutional investors. Comparatively, 98.9% of Celanese shares are owned by institutional investors. 0.4% of Albemarle shares are owned by company insiders. Comparatively, 0.3% of Celanese shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Albemarle currently has a consensus price target of $199.58, indicating a potential upside of 47.55%. Celanese has a consensus price target of $65.69, indicating a potential upside of 37.94%. Given Albemarle's stronger consensus rating and higher probable upside, analysts plainly believe Albemarle is more favorable than Celanese.

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.2%. Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.3%. Albemarle pays out -47.5% of its earnings in the form of a dividend. Celanese pays out -1.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has increased its dividend for 30 consecutive years. Albemarle is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Albemarle has a net margin of -5.00% compared to Celanese's net margin of -11.54%. Celanese's return on equity of 9.92% beat Albemarle's return on equity.

In the previous week, Albemarle had 6 more articles in the media than Celanese. MarketBeat recorded 14 mentions for Albemarle and 8 mentions for Celanese. Albemarle's average media sentiment score of 0.74 beat Celanese's score of 0.29 indicating that Albemarle is being referred to more favorably in the media.

Albemarle has a beta of 1.34, suggesting that its share price is 34% more volatile than the broader market. Comparatively, Celanese has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market.

Albemarle has higher earnings, but lower revenue than Celanese. Albemarle is trading at a lower price-to-earnings ratio than Celanese, indicating that it is currently the more affordable of the two stocks.